600085.SS

Beijing Tongrentang Co., Ltd 600085.SS

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode 600085.SS 000999.SZ 000661.SZ 600332.SS 688578.SS 300832.SZ 300759.SZ 600079.SS 300896.SZ 002252.SZ
6M -5.79 % -17.30 % 33.04 % -2.59 % 21.96 % 18.56 % 37.46 % 1.23 % -5.99 % -2.49 %
YTD -13.98 % -14.33 % 25.87 % -7.26 % 75.52 % -8.37 % 22.33 % -7.11 % -4.59 % -7.62 %
1Y -13.26 % -21.24 % 18.17 % -10.95 % 87.73 % -9.73 % 8.80 % -9.67 % -22.61 % -6.84 %
3Y -33.07 % 4.34 % -37.18 % -6.04 % 354.55 % 9.44 % -17.70 % 1.83 % -49.04 % 21.27 %
5Y 27.13 % 81.59 % -66.85 % -22.78 % 169.55 % -37.39 % -35.72 % -33.03 % -2.07 % -24.72 %
10Y 34.47 % 87.09 % 150.68 % -9.08 % 169.55 % 155.32 % 528.37 % 10.79 % 24.68 % -71.59 %
From the beginning 1 260.80 % 1 780.79 % 3 652.45 % 403.55 % 169.55 % 155.32 % 528.37 % 1 072.73 % 24.68 % 254.79 %

Dividend

Beijing Tongrentang Co., Ltd

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

Changchun High-Tech Industries (Group) Inc.

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited

Shanghai Allist Pharmaceuticals Co., Ltd.

Shenzhen New Industries Biomedical Engineering Co., Ltd.

Pharmaron Beijing Co., Ltd.

Humanwell Healthcare (Group) Co.,Ltd.

Imeik Technology Development Co.,Ltd.

Shanghai RAAS Blood Products Co., Ltd.